Clinical and Laboratory Standards Institute
| The Clinical and Laboratory Standards Institute (CLSI) is a global, nonprofit, standards-developing organization that promotes the development and use of voluntary consensus standards and guidelines within the healthcare community. For healthcare professionals, CLSI documents offer practical operating guidelines that lead to consistent practices, precision, and efficient use of resources. For industry, they promote effective use of healthcare technologies, and provide cost-and time-saving procedures for product development and approval. For government, these tools streamline the regulatory process. For the entire healthcare community, CLSI documents assure the levels of excellence and consistency that promote improved quality of life. |
and We Provide them for you with cheap price
Selecte from techstreet andÂ
| Document Number | Title | Pub Date | Status |
| CLSI POCT14 | Point-of-Care Coagulation Testing and Anticoagulation Monitoring – Second edition; Vol 40, No 10 | 2020 | Active |
| CLSI M23S | Procedure for Optimizing Disk Contents (Potencies) for Disk Diffusion Testing of Antimicrobial Agents Using Harmonized CLSI and EUCAST Criteria – 1st Edition; Vol 40; No 6 | 2020 | Active |
| CLSI M61 | Performance Standards for Antifungal Susceptibility Testing of Filamentous Fungi – Second Edition; Vol 40; No 9 | 2020 | Active |
| CLSI M60 | Performance Standards for Antifungal Susceptibility Testing of Yeasts – Sedond Edition; Vol 40; No 8 | 2020 | Active |
| CLSI M59 | Epidemiological Cutoff Values for Antifungal Susceptibility Testing – Third Edition; Vol 40; No 7 | 2020 | Active |
| CLSI QMS05 | Qualifying, Selecting, and Evaluating a Referral Laboratory – 3rd Edition; Vol 40; No 5 | 2020 | Active |
| CLSI VET03 | Methods for Antimicrobial Broth Dilution and Disk Diffusion Susceptibility Testing of Bacteria Isolated From Aquatic Animals – 2nd Edition; Vol 40; No 3 | 2020 | Active |
| CLSI VET04 | Performance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals – 3rd Edition; Vol 40; No 4 | 2020 | Active |
| CLSI M100 | Performance Standards for Antimicrobial Susceptibility Testing – 30th Edition; Vol 40; No 1 | 2020 | Active |
| CLSI POCT15 | Point-of-Care Testing for Infectious Diseases – 1st Edition; Vol 40; No 2 | 2020 | Active |
| CLSI EP35 | Assessment of Equivalence or Suitability of Specimen Types for Medical Laboratory Measurement Procedures – First Edition: Vol 39: No 13 | 2019 | Active |
| CLSI NBS05 | Newborn Screening for Cystic Fibrosis – Second Edition; Vol 39; No 14 | 2019 | Active |
| CLSI NBS08 | Newborn Screening for Hemoglobinopathies – First Edition; Vol 39; No 12 | 2019 | Active |
| CLSI AUTO15 | Autoverification of Medical Laboratory Results for Specific Disciplines – 1st Edition; Volume 39, Number 11 | 2019 | Active |
| CLSI NBS03 | Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns – Second Edition; Vol 39; No 9 | 2019 | Active |
| CLSI VET09 | Understanding Susceptibility Test Data as a Component of Antimicrobial Stewardship in Veterinary Settings – 1st Edition | 2019 | Active |
| CLSI QMS01 | A Quality Management System Model for Laboratory Services – 5th Edition; Vol 39; No 6 | 2019 | Active |
| CLSI QMS23 | General Laboratory Equipment Performance Qualification, Use, and Maintenance – Second Edition; Vol 39; No 7 | 2019 | Active |
| CLSI AUTO16 | Next-Generation In Vitro Diagnostic Instrument Interface – 1st Edition; Volume 39; Number 4 | 2019 | Active |
| CLSI GP33 | Accuracy in Patient and Specimen Identification – Second Edition; Vol. 39; No. 5 | 2019 | Active |
| CLSI C34 | Sweat Testing: Specimen Collection and Quantitative Chloride Analysis – Fourth Edition | 2019 | Active |

